ASX 200 morning report – FMG, RIO & IRE shares in focus
Drew Meredith, CFP
September 20, 2021
The S&P/ASX 200 fell 0.8% on Friday, erasing the week’s
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The S&P/ASX 200 fell 0.8% on Friday, erasing the week’s
The S&P/ASX 200 (ASX: XJO) dropped another 0.3% on Wednesday
Might the CSL Limited (ASX:CSL) share price be an opportunity
The Nanosonics Ltd (ASX: NAN) share price has gone bonkers
A look at Pro Medicus Ltd (ASX:PME), Redbubble Ltd (ASX:RBL),
On The Australian Investors Podcast, watch or listen along as
What a week of ASX Reporting Season! The results are
The S&P/ASX 200 (ASX: XJO) fell 0.1% on Wednesday solely
Australia’s third-largest public company CSL Limited (ASX: CSL) achieved steady
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
